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Detection and characterization of chemically induced toxic effects in the nervous system
represent a challenge for the hazard assessment of chemicals. In vivo, neurotoxicological
assessments exploit the fact that the activity of neurons in the central and peripheral ner-
vous system has functional consequences. And so far, no in vitro method for evaluating
the neurotoxic hazard has yet been validated and accepted for regulatory purpose. The
micro-electrode array (MEA) assay consists of a culture chamber into which an integrated
array of micro-electrodes is capable of measuring extracellular electrophysiology (spikes
and bursts) from electro-active tissues. A wide variety of electrically excitable biological
tissues may be placed onto the chips including primary cultures of nervous system tis-
sue. Recordings from this type of in vitro cultured system are non-invasive, give label free
evaluations and provide a higher throughput than conventional electrophysiological tech-
niques. In this paper, 20 substances were tested in a blinded study for their toxicity and
dose–response curves were obtained from fetal rat cortical neuronal networks coupled
to MEAs. The experimental procedure consisted of evaluating the ﬁring activity (spiking
rate) and modiﬁcation/reduction in response to chemical administration. Native/reference
activity, 30min of activity recording per dilution, plus the recovery points (after 24 h) were
recorded. The preliminary data, using a set of chemicals with different mode-of-actions
(13 known to be neurotoxic, 2 non-neuroactive and not toxic, and 5 non-neuroactive but
toxic) show good predictivity (sensitivity: 0.77; speciﬁcity: 0.86; accuracy: 0.85). Thus, the
MEA with a neuronal network has the potency to become an effective tool to evaluate the
neurotoxicity of substances in vitro.
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INTRODUCTION
Thedetermination of the toxicity proﬁle of different chemical, bio-
logical, and pharmacological compounds is outlined in the current
international testing guidelines (OECD, 1997; US EPA, 1998). An
important element of the hazard assessment is the evaluation of
potential neurotoxic effects (Crofton et al., 2004; Coecke et al.,
2006). An agent is considered neurotoxic if an alteration in the
structure or function in any part of the central and/or periph-
eral nervous system can be observed following acute or chronic
exposure, at concentrations that do not affect general viability
(Costa, 1998). A neurotoxic effect can be the direct alteration
of the neurons structure or activity or can be the result of cas-
cade effects due to glia activation and glia-neuron interactions; a
neurotoxic effect can manifest immediately or delayed after the
substance administration, it can be permanent or reversible, and it
can affect the whole nervous system as well as parts of it (Monnet-
Tschudi et al., 1997; Philbert et al., 2000; Tabakman et al., 2004;
Coecke et al., 2006).
Current directives for the evaluation of neurotoxic hazard
(OECD, 1997; US EPA, 1998) are based on in vivo studies assessing
neurophysiological,neuropathological,neurobehavioral, andneu-
rochemical endpoints (Johnstone et al., 2010). These methods are
expensive and time consuming,have a low throughput, and involve
the use of a larger amount of test substances and animals.
The need efﬁcient testing and recent directives on animal use
for laboratory tests is pushing the development and validation
of new testing strategies based on alternative methods (Har-
tung et al., 2003, 2004), in which the use of time, materials,
and animals is reduced and reﬁned or animal use is completely
replaced (3R).
To date, no in vitro method has been validated for the neuro-
toxicology assessment, and one of the recent and most promising
tools for neurotoxicity assessment is the measurement of elec-
trical activity using micro-electrode array (MEA) chips. This
technique is recording whole neuronal ensembles as functional
networks and provides more relevant physiological information
than other methods for electrophysiology assessment, e.g., patch
clamps. The MEA-based recordings testing techniques dates back
to the early eighties (Gross et al., 1982) and the technology behind
has been improved since then (Gross et al., 1993; Breckenridge
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et al., 1995; Potter, 2001). Today many different in vitro models
can be studied by MEA-based systems such as hippocampus slices,
primary mammalian dissociated cultures and stem cells.
Mammalian neuronal networks cultured from different brain
structures on MEA chips remain spontaneously active and stable
for many months (Gross et al., 1982; Potter and DeMarse, 2001;
Gramowski et al., 2004; Van Pelt et al., 2004a,b). Moreover, these
models respond to neurotransmitters and their blockers in a sim-
ilar way as the in vivo situation (Streit, 1993; Gramowski et al.,
2000; Keefer et al., 2001a,b; Martinoia et al., 2005). Primary cul-
tures grown on MEA chips have been used in many studies of
pharmacological and toxicological responses, and acute neurotox-
icity detection (Gross et al., 1997; Gramowski et al., 2000, 2006;
Moreﬁeld et al., 2000;Keefer et al., 2001b;Pancrazio et al., 2003;Xia
and Gross, 2003; Xia et al., 2003; Sundstrom et al., 2005; Parviz and
Gross, 2007; vanVliet et al., 2007). A very recent review (Johnstone
et al., 2010) describes the state of the art of MEA-based assays for
neurotoxicity assessment.
In this study, electrical activity measurements were evaluated
to see whether they are a reliable, accurate, and robust endpoint
for the detection of neurotoxicity and could be suitable for predic-
tive purposes in the chemical industry. To this end, 20 substances
were selected, blinded at BASF (Germany) and then sent to ETT
(Italy) to perform the test. The substances were selected according
to their neurotoxic effects in vivo: 13 substances known to be neu-
roactive, 2 non-neuroactive and non-toxic and 5 non-neuroactive
but toxic.
MATERIALS AND METHODS
CHEMICALS
For the study purpose 20 substances were selected at BASF
(Germany) and sent to ETT (Italy) to perform the blind test. Some
substances were selected according to their already known effect;
some others are completely new for the MEA-based system lit-
erature. A set of 20 chemicals with different mode-of-actions (2
non-neuroactive andnot toxic,Table 1; 5 not neuroactive but toxic,
Table 2; 13 known to be neurotoxic, Table 3 substances) was pre-
pared for the blind test. In particular the following set was selected
and labeled as follows: (S1) Ibuprofen (CAS#:15687-27-1), (S2)
1,2,4-Trichlorobenzene (CAS#: 120-82-1), (S3) Trimethyltin chlo-
ride (CAS#: 1066-45-1), (S4) (2,4-Dichlorophenoxy) acetic acid
sodium salt (CAS#: 2702-72-9), (S5) p-Cresol (CAS#: 106-44-5),
(S6) Ethanol (CAS#: 64-17-5), (S7) Salicylic acid (CAS#: 69-72-7),
(S8)Mepiquat chloride (CAS#: 24307-26-4), (S11) 1,2-Propandiol
(CAS#: 57-55-6), (S13) Tetrahydroisoquinoline (THIQ; CAS#:
91-21-4), (S14) Toluene (CAS#: 108-88-3), (S15) Aniline (CAS#:
62-53-3), (S16) Nicotine (CAS#: 54-11-5), (S17) Fipronil (CAS#:
120068-37-3), (S19) Quinmerac (CAS#: 90717-03-6), (S20) Car-
baryl (CAS#: 63-25-2), (S21) Nomifensine maleate salt (CAS#:
24526-64-5), (S22) Paraquat Dichloride (CAS#: 1910-42-5), (S23)
Eugenol (CAS#: 97-53-0), (S24) Diphenhydramine hydrochloride
(CAS#: 147-24-0). The 20 substances (12 powders and 8 liquids)
were shipped in sealed amber glass vials labeledwith numbers only
(numbers from 1 to 24, 4 substances were omitted from the test).
The set included 8 water soluble substances, and 12 water insol-
uble ones, which were diluted using DMSO. Each substance was
dissolved to a 100-mM stock solution and then divided in aliquots
stored at −20˚C.
CELL CULTURE
Three different rat strains, namely Wistar SPF, Sprague-Dawley,
and CD SPF/VAF F were employed to prove the reliability of
results on the same district from different animal sources. The
primary cultures of cortical neurons were prepared from fetal
day 18 rats according to previously described procedures (Chi-
appalone et al., 2006). Brieﬂy, the cortex was dissociated through
enzymatic and mechanical dissociation (0.125% Trypsin – DNAse
I 0.025mg/ml – BSA 0.3% solution in HBSS without calcium and
magnesium). The cells were seeded on standard 60-electrode TiN-
SiN MEA chips with internal reference (Multi Channel Systems,
Reutlingen, Germany) pre-coated with poly-D-lysine and laminin
(0.1mg/ml diluted in sterileMilliQwater) as 50μl droplets (1500–
2000 cells/mm2), with subsequent addition of 1ml of medium
after the cells were attached (approximately 2 h). Cultures were
maintained in neurobasal (NB) medium supplemented with 2%
B27 and 1% Glutamax-I, and half volume of the medium was
Table 1 | Description and properties of the non-neuroactive and non-toxic substances utilized.
Chemical Legal classification of Description
acute oral toxicity in
the European Union
(ECB–JRC)1
1,2-Propandiol (S11) NO 1,2-Propandiol is used an intermediate in the chemical industry, as a solvent in pharmaceuticals and as
a food additive (E1520). In humans, pronounced toxicity was only observed at plasma concentrations
above 1 g/L (about 13mM; Flanagan et al., 1995)
Quinmerac (S19) NO Quinmerac is a quinoline carboxylic acid that is used as a systemic herbicide. It acts as a root growth
inhibitor because it mimics the effects of supra optimal endogenous auxin concentrations (Grossmann
et al., 2001). Quinmerac has a low acute systemic toxicity with an oral LD50 above 5000mg/kg in rats2
1http://ecb.jrc.ec.europa.eu/esis/index.php?PGM=cla
2http://www.pesticides.gov.uk/PSD_PDFs/Evaluations/177_quinmerac.pdf
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Table 2 | Description and properties of the toxic but non-neuroactive substances utilized.
Description Legal classification Description
Ibuprofen (S1) NO Ibuprofen [2-(4-isobutylphenyl) propionic acid] is a non-steroidal anti-inﬂammatory drug
(NSAID). It exerts its pharmacological action inhibiting the cyclooxygenase enzymes (COX).
Overdoses may cause renal toxicity, hepatotoxicity but no neurotoxicity has been described
(Nanau and Neuman, 2010)
(2,4-Dichlorophenoxy)acetic
acid (S4)
NO (2,4-Dichlorophenoxy)acetic acid is an herbicide. Target organs of mammalian toxicity are
kidneys and liver but not the nervous system (Uyanikgil et al., 2009; Tayeb et al., 2010)
Salicylic acid (S7) NO Salycilic acid is known to inhibit cyclooxygenase. High doses of salicylate lead to a pyretic effect
which is probably a direct result of the uncoupling of oxidative phosphorylation (Battaglia et al.,
2005)
An oral LD50 of 891mg/kg body weight was reported for rats (BIOFAX Industrial Bio-Test
Laboratories, Inc., Data Sheets. Vol. 21-3/1971)
Aniline (S15) Acutely toxic by
inhalation, skin contact
and oral uptake (H301,
311, 331)
Aniline is an aromatic amine used as intermediate in the production of various chemicals. It
is linked to the onset of methhemoglobinaemia (Gelpí et al., 2002)
Paraquat dichloride (S22) Acutely toxic by
inhalation, skin contact
and oral uptake (H301,
311, 331)
Paraquat Dichloride is an herbicide. It is known to be toxic to humans, exerting acute effects
by redox cycling generating intracellular oxidative stress in the lung (Dinis-Oliveira et al., 2008)
Recently, chronic exposition to paraquat have been linked to the onset of neurotoxicity affect-
ing dopaminergic system neurons (Ossowska et al., 2006;Thrash et al., 2007), these ﬁndings
are still under discussion (Miller, 2007)
exchanged once a week. Cells were maintained at 37˚C in a
humidiﬁed atmosphere of 5% CO2 until their use.
EXPERIMENTAL LAYOUT
Experiments were carried from 25 to 54 days in vitro (DIV), when
neuronal networks are mature (Novellino and Zaldívar, 2010).
Each substance was tested at least three times and using neu-
ronal networks from different neuronal isolations. Any neuronal
network was used only once. In order to stabilize the culture con-
dition, a 50% medium change was performed 48 h before testing.
The day of the experiment the seven test dilutions (100 nM, 1μM,
10μM, 100μM, 1mM, 10mM, 100mM) were freshly made by
diluting the thawed mother solution into the solvent (H2O or
DMSO). The culture medium volume was checked to be 1ml
before any experimental session.
Reagents were then introduced by the following pipetting pro-
cedure to ensure proper mixing: 200μl of medium was removed
from the medium bath covering the networks, mixed with a small
volume (1μl) of the reagent dilution and carefully returned to
the medium bath in order to minimize any osmotic or hydro-
dynamic stress. In case of water as solvent additional 0.9μL of
DMSO was added to the culture medium at any administration
in order to expose any neuronal network to the same amount
of DMSO. Typically concentration–response relationships were
determined in a cumulativemanner, in which the concentration of
drug present in the medium was increased in a stepwise method in
log units.
At least two recovery tests were performed for any substance
after 24 h, in particular the medium was completely changed
after the experiment, and MEA returned to the incubator for
24 h. The spontaneous activity was recorded for 30min and
compared to the activity recorded from the same culture the
day before.
DATA RECORDINGS AND SIGNAL PROCESSING
Standard 60-electrode MEA chips (with 30μm diameter elec-
trodes, 200μm inter-electrode spacingwith/without an integrated
reference electrode) were employed. The activity was recorded by
the MEA1060 System from Multi Channel Systems (MCS GmbH,
Reutlingen, Germany, http://www.multichannelsystems.com).
The system also included a temperature controller (TC02, MCS
GmbH) that allowed heating of the MEA chips and thus the
medium from the bottom. During recordings, cells were kept at
37˚C and in a controlled humid atmosphere (5% CO2, 20% O2
and N2) to buffer the supernatant pH (pH was 7.1± 0.1 during
whole experiments). The MEA chips were placed into the MEA
Ampliﬁer (Gain 1000×) and data were recorded by the MC_Rack
software at a sampling rate of 10 kHz.A bandpass digital ﬁlter (60–
4000Hz)was applied to the raw signal in order to remove electrical
background noise. Spike trains were extracted by the MC_Rack
spike detection: if the electric signal overcomes the spike detection
threshold (i.e., 6.0± 0.5 times the SD of the mean square root
noise) the spike is identiﬁed and recorded.
All analyses were conducted on binned data with bin size of
60 s. Data from experimental episodes were averaged for the last
20min over the 30-min time window of recording for each con-
centration and the network mean ﬁring rate (MFR) was extracted
as a descriptor of the network activity level. Each time point of
the experiment was the average of the ﬁring rate over a 60-s time
period. A stable level of spontaneous activity was required in order
to start the experiment andwas considered as the reference. In gen-
eral, there is a transitionperioduntil equilibrium is achievedwhich
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Table 3 | Description and properties of the neurotoxic substances utilized.
Description Legal classification Description
1,2,4-Trichlorobenzene
(TCB; S2)
Harmful if swallowed (H302) Rats and mice manifested symptoms of depressed activity at lower doses
of TCB and extensor convulsions at lethal doses (IPCS, 1991). Tremors fol-
lowed by death within 20–30 days occurred in monkeys exposed orally to
174mg/kg/day (US EPA, 1994)
Trimethyltin chloride (S3) Fatal if inhaled, in contact with skin and
if swallowed (H300, 310, 330)
Trimethyltin chloride is a potent neurotoxic agent
It produces lesions primarily in the limbic system, including those in the hip-
pocampus, fascia dentata, pyriform cortex, entorhinal cortex, and amygdaloid
nucleus (Brown et al., 1979; Bouldin et al., 1981; Chang et al., 1982; Dyer et al.,
1982; Philbert et al., 2000)
p-Cresol (S5) Toxic in contact with skin and if
swallowed (H301, 311)
p-Cresol damages the CNS if inhaled (Kavitha and Palanivelu, 2005) by various
toxic effects, like decreasing the response of activated polymorphonuclears,
inhibition of platelet activating factor synthesis by human adherent mono-
cytes and decrease of the endothelial cell response to inﬂammatory cytokines
(D’Hooge et al., 2003; Schepers et al., 2007)
Ethanol (S6) NO Ethanol stimulates the GABA-receptors in the nervous system and blocks the
NMDA-receptors. Therefore, high amounts of ethanol leads to programmed
cell death of the neuronal cells (Xia and Gross, 2003; Pohl-Guimaraes et al.,
2010)
Mepiquat chloride (S8) Harmful if swallowed (H302) Mepiquat chloride is a plant growth regulator that inhibits the biosynthesis of
gibberellic acid
In rats, mepiquat chloride had an acute oral LD50 of 464mg/kg body weight.
Additionally, in an acute oral neurotoxicity study in rats the NOAEL was
100mg/kg body weight based on observations of decreased motor activity at
doses of 300mg/kg and above.The effect was attributed to reversible binding
of mepiquat to nicotinic and muscarinic receptors (EFSA, 2008)
Tetrahydroisoquinoline
(THIQ; S13)
NO Tetrahydroisoquinoline (THIQ) is a secondary aromatic amine. Used as inter-
mediate and formed as a metabolite. It is structurally related to several
neuroactive compounds Endogenous production of neurotoxic tetrahydroiso-
quinoline derivatives from certain drugs such as norsalsolinol is investigated
as possible cause for neurological disease (Abe et al., 2005)
Toluene (S14) Toxic effects (H 361d, 304, 373, 315,
336) including (H336) induction of
dizziness and drowsiness
Toluene is a volatile organic solvent, which is widely used in industry and a
number of commercial products. It readily crosses the blood–brain barrier
after inhalation and produces effects similar to that of sedative–hypnotics,
such as alcohol and benzodiazepines (Balster, 1998).The mechanism has not
yet been clariﬁed. In chronic toluene abusers cerebellar dysfunction and cere-
bral and hippocampal atrophy as well as a loss of brain volume was found
(Yamanouchi et al., 1995; Kamran and Bakshi, 1998; Deleu and Hanssens,
2000; Win-Shwe and Fujimaki, 2010)
Nicotine (S16) Toxic in contact with skin and if
swallowed (H301, 310)
Nicotine is an alkaloid naturally present in members of the Solanaceae family
of plants. It acts as an agonist for nicotinic cholinergic receptors (nAChR),
which is a non-selective cation channel. (Lindstro, 1997)
Fipronil (S17) Acute toxicity by inhalation, skin contact
and if swallowed (H331, 311, 301).
Fipronil is a phenylpyrazole and used as an insecticide and akaricide. It blocks
the GABAa receptors (chloride-ion channel), which causes a hyper excitation
of the parasite
Carbaryl (S20) Acute toxicity by inhalation and if
swallowed (H332, 302)
Carbaryl is a contact insecticide from the carbamate group. It acts on the
CNS of insects by blocking the Acetylcholine esterase (AChE). This results in
the enrichment of acetylcholine at the postsynaptic membrane which causes
permanent agitation.The consequences are paralysis, apnoea, and eventually
mortality (Gupta, 2006). In mammalian models, it elicited a marked hypother-
mia and reduction in motor activity in rats when administered orally at doses
that inhibit brain AChE activity (Gordon et al., 2006)
(Continued)
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Table 3 | Continued
Description Legal classification Description
Nomifensin maleate (S21) NO Nomifensin maleate had been used as an antidepressant and anesthetic because
it blocks the dopamine reuptake in the brain at low levels (10μM). It also induces
hemolytic anemia and was therefore removed from the market. (Kinney, 1985;
Nuwayhid and Werling, 2006; Obach and Dalvie, 2006)
Eugenol (S23) NO Eugenol is used in dentistry as a local analgesic agent.The induced sedation and
loss of consciousness in rats in a dose-dependent manner (Guenette et al., 2006).
CNS depression was also reported with acute intoxication of humans (Lane et al.,
1991)
Diphenhydramine
hydrochloride (S24)
NO Diphenhydramine hydrochlorid is a ﬁrst generation antihistamine, which can pen-
etrate the blood–brain barrier. Like several other ﬁrst generation antihistamines,
it is also a potent competitive antagonist of muscarinic cholinergic receptors
and furthermore is able to block the reuptake of serotonin (Sewell et al., 1985).
Diphenhydramine causes sedation, due to its histamine H1 receptor antagonism.
Table 4 | Results of the blinded test of the 20 substances.
Substance Toxicological classification MFR MFR MFR Estimated IC50 Recovery
excitation reduction total cessation
Quinmerac A
1,2-Propandiol B
2,4-D sodium salt Toxic but not neuroactive A
Ibuprofene Toxic but not neuroactive B
Salicylic acid Toxic but not neuroactive B
Paraquat Dichloride Toxic but not neuroactive B
Aniline Toxic but not neuroactive x B
Nicotine Neuroactive x B
Ethanol Neuroactive A
Toluene Neuroactive B
Mepiquat chloride Neuroactive B
1,2,4-Trichlorobenzene Neuroactive x 60μM B
Tetrahydroisoquinoline Neuroactive x 20μM B
p-Cresol (4-Methylphenol) Neuroactive x 1–10μM B
Fipronil Neuroactive x x 65–90μM B
Carbaryl (1-Naphthylmethylcarbamat) Neuroactive x x 25–65μM A
Nomifensin maleate salt Neuroactive x x 10–20μM A
Diphenhydramine hydrochloride Neuroactive x x 5–20μM B
Eugenol Neuroactive x x 3–7μM C
Trimethyltin chloride Neuroactive x x 1–10μM C
Resume of the results obtained for the tested substances, ordered following their toxicological classiﬁcation (no toxicity, toxic but not neuroactive, or neuroactive)
and their toxic potency. Effects on MFR are indicated, as well as the registered recovery (A: good recovery, B: average recovery, C: poor recovery), and a range for
the estimated IC50.
has been established by each laboratory with post hoc analysis in
previous experiments. The response during this transition time
window has not been considered for the concentration–response
analysis The percent change in ﬁring rate at each concentration
was then determined relative to the reference spontaneous activity
period.
To determine the changes of network activity with time, mean
network spike rate of all active channels over the course of the
whole experiment were considered. For the purpose of obtain-
ing the IC50 values from the dose–response curve the changes
in MFR were considered. Plots were also used to determine the
concentration that stopped the activity completely.
CHANNEL INCLUSION/EXCLUSION CRITERION
Some simple rules were used for considering the neuronal network
and its activity acceptable. The ﬁrst criterion was based on the net-
work morphology evaluation done by a trained and experienced
operator. On a regular basis during the culture time and prior
to MEA recording each chip was inspected under microscope to
check for the neuronal network morphology and growth basing
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on the presence of a dense and uniform distribution of neuronal
cells and the presence of neuronal connections on the recording
area as previously described (Hogberg et al., 2011). The second
criterion was based on the electrophysiological activity analy-
sis, and both noisy and silent channels were excluded from the
analysis. In particular during the reference activity if the sponta-
neous ﬁring rate was lower than 10 spikes/bin (bin size of 60 s) the
channel was considered a silent channel, and if the spontaneous
ﬁring rate was higher than 200 spikes/bin the channel was con-
sidered a noisy channel. The average of the excluded channel was
19.96± 0.77.
SINGLE DOSE–RESPONSE ACCEPTANCE CRITERIA
The aim of the investigation was to extract the mean effect of
the chemical on the activity of the neuronal network once the
interaction between the chemical and the neurons’ receptors had
reached the saturation phase, the CVTIME of spike rate, i.e.,
the coefﬁcient of variation of the spike rate in time, was stud-
ied to check the stability of the neuronal network activity after
the chemical administration. The CV, in general calculated by
CV= SD/mean, was used to describe the spatiotemporal behavior
of thenetwork activity (Keefer et al., 2001a;Gramowski et al., 2004)
and the CVTIME quantify the spatiotemporal behavior reﬂecting
temporal dynamics and the fundamental interactions within the
networks. The CVTIME was extracted for each channel and the
average of the CVTIME was used as a further exclusion criterion.
If the CVTIME never reached and stabilized the 20% for more
than one administration, the experiment was rejected. In average
the CVTIME reached and stabilized down the threshold by 10min
after the chemical administration.
STATISTICAL ANALYSIS
The Igor Pro 6.1 (Wavemetrics Inc., USA) program was used for
statistical analyses. All data given are means of at least three inde-
pendent experiments± SEM. Student’s one tail paired t -test was
performed to assess differences between basal spontaneous activity
and activity after chemical administration. Statistical signiﬁcance
was indicated for P < 0.05. The averaged spike rate as a function
of the concentration was ﬁtted to both Hill Equation and Sigmoid
Fitting tool for estimating the IC50 value.
The predictivity parameters have been calculated according to
the following formulae:
Speciﬁcity = number of true negatives/number of true
negatives+ number of false positives
Sensitivity = number of true positives/number of true
positives+ number of false negatives
Accuracy = correct identiﬁed analytes (positives andnegatives)/
total number of analytes.
RESULTS
To assess the maturation of a neuronal network on MEA, the
spontaneous activity of a MEA chip was measured every week.
As already described (Van Pelt et al., 2005; Wagenaar et al., 2006;
Hogberg et al., 2011), at the early time point (7 DIV) only a few of
the cultures have shown spontaneous activity that was weak (few
active channels and no synchronized pattern), then the activity
increased over time and became more and more synchronized
with the typical bursting and spiking pattern of cortical neuronal
cultures at the age of 28 DIV.
At the maturation time, i.e., after 4 week of in vitro culture,
the neuronal networks exhibited spontaneous activity in their
respective media, consistent with previously reported effects (Xia
et al., 2003; Gramowski et al., 2004; Chiappalone et al., 2006;
Shafer et al., 2008).
Network spike rates ranged from (mean ± SEM) 55.06± 6.98
spikes/s (n = 60).
During experiments any neuronal network was exposed to
DMSO at a ﬁnal concentration of 0.7%. In order to check
the DMSO induced effects, control experiments were performed
both with a one-step as well as with progressive administrations
and no effects of DMSO on spontaneous activity were recorded
(data not shown).
The tested substances were supposed to fall in three main
groups according their biological activities based on legal clas-
siﬁcation (EBC–JRC) and published in vivo and in vitro data,
namely (1) not neuroactive and not toxic, (2) toxic but not neu-
roactive, and (3) neurotoxic substances. The results obtained are
summarized in Table 4.
NOT NEUROACTIVE AND NOT TOXIC SUBSTANCES
In accordance to their in vivo data, these two substances had no
signiﬁcant effect on network activity (Figure 1). 1,2 Propandiol
caused a slight increase in the ﬁring rate at high concentrations,
but this effect is not statistically signiﬁcant.
TOXIC BUT NOT NEUROACTIVE SUBSTANCES
The substances in this group had no signiﬁcant effect on MFR, as
expected, at the concentrations tested, with the exception of ani-
line that presented a mild but signiﬁcant progressive increase in
the MFR during the experiment (Figure 2).
NEUROACTIVE SUBSTANCES
Nine of the thirteen substances in this group showed a signiﬁcant
effect on neuronal network activity (Figure 3). All the substances
that caused an MFR reduction, or its total cessation, belongs to
this group. Nicotine showed a slight increase in MFR at the maxi-
mum tested concentration. And three substances, namely ethanol,
mepiquat, and toluene, did not show a signiﬁcant effect.
RECOVERY TESTS
To have an indication about the reversibility of the effects of the
substances utilized, a recovery test was performed after 24 h fol-
lowing a complete medium wash-out, and the electrical activity
compared to the basal activity recorded on the same culture the
day before. The recovery results were classiﬁed according to a three
level scale: A – good recovery (level of activity more than 70% of
the spontaneous activity recorded during the reference period the
day before); B – average recovery (level of activity between 35 and
70%); C – poor recovery (recovered activity less than 35%). Five
substances showed a good recovery (Table 4), and two of them
[Carbaryl (S20) and Nomifensine (S21)] initially showed high
neuroactivity, indicating the reversibility of their effects. TMT (S3)
and Eugenol (S23) had a poor recovery, which indicates that there
was a strong neuroactive effect that ended in cytotoxicity. For all
the other substances the recovery was average.
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FIGURE 1 | Electrical activity effects on neuronal cultures after
administration of not neuroactive and not toxic substances. Electrical
activity following administration of substances classiﬁed in the not
neuroactive and not toxic group (at the concentration indicated under the
bars) has been recorded and normalized in respect to native activity (percent
of control, indicated as 100 in the ordinate axis). All data are means of at least
three independent experiments±SEM. Student’s one tail paired t -test was
performed to assess differences between basal spontaneous activity and
activity after chemical administration. Statistical signiﬁcance was indicated by
* for P < 0.05.
FIGURE 2 | Electrical activity effects on neuronal cultures after
administration of toxic but not neuroactive substances. Electrical
activity following administration of substances classiﬁed in the toxic but not
neuroactive group (at the concentration indicated under the bars) has been
recorded and normalized in respect to native activity (percent of control,
indicated as 100 in the ordinate axis). All data are means of at least three
independent experiments±SEM. Student’s one tail paired t -test was
performed to assess differences between basal spontaneous activity and
activity after chemical administration. Statistical signiﬁcance was indicated
by * for P < 0.05.
DISCUSSION
The problem of toxicity assessment of all chemicals sold in Europe
according to the REACH regulation is particularly challenging:
a recent research (Hartung and Rovida, 2009) presented a very
critical situation. Industries are already facing the submission of
existing toxicity data and animal-testing plans for part of the “old”
chemicals because much information, such as reproductive tox-
icity, neurotoxicity, developmental neurotoxicity, etc., is missing.
Current in vivo test methods are based on behavioral and sensory
perturbations coupled with routine histopathological investiga-
tions. In spite of the empirical usefulness of these tests, they
are not always sensitive enough, and often they do not provide
information that facilitates a detailed understanding of potential
mechanisms of toxicity, thus enabling predictions. Regarding the
status of in vitro tests, they are generally not used to detect neu-
rotoxicity for prediction of hazards to human health and so far
they play a complementary role to the in vivo tests (Bal-Price et al.,
2010). Furthermore, the current in vitro test methods are far from
being capable of testing large numbers of chemicals in a short
time. High throughput and high content screening (HTS/HTC)
methods have been proposed as an integral component of future
toxicity testing strategies (Costa, 1998; Coecke et al., 2006; Lein
et al., 2007; NRC, 2007). However, they are often not designed to
assess the physiology and functionality of living neurons, which
may result in missing the effects of some chemicals and/or ham-
per the identiﬁcation of toxicity pathways related to higher level
functions of the nervous system. The set up and validation of an
alternative in vitro method constitute therefore a topic of central
interest in order to reduce, reﬁne and replace animal-testing.
So far, the MEA technique has been used in several pharmaco-
logical and toxicological studies (Gross et al., 1997; Gramowski
et al., 2000,2006; Moreﬁeld et al., 2000; Keefer et al., 2001b;
Sundstrom et al., 2005; Parviz and Gross, 2007; van Vliet et al.,
2007) and the IC50 ranges have been established in the same range
as those published for other toxicological studies and are in general
in agreement with those obtained from animal experiments (Xia
and Gross, 2003; Xia et al., 2003). However, until now MEAs were
not tested as an in vitro model for neurotoxicity testing of large
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FIGURE 3 | Electrical activity effects on neuronal cultures after
administration of neuroactive substances. Electrical activity following
administration of substances classiﬁed in the neuroactive group (at the
concentration indicated under the bars) has been recorded and normalized
in respect to native activity (percent of control, indicated as 100 in the
ordinate axis). All data are means of at least three independent
experiments±SEM. Student’s one tail paired t -test was performed to
assess differences between basal spontaneous activity and activity after
chemical administration. Statistical signiﬁcance was indicated by * for
P < 0.05.
varieties of chemicals. Comparing the results from this study with
neuronal network on MEA to published in vivo data, there were
10 substances identiﬁed as true positives, 1 as false positive, 6 true
negative and 3 false negative. Based on these data the sensitivity
of the assay was 77% and the speciﬁcity was 86%. This makes an
overall accuracy of 80% for the assay.
PARAMETERS EXTRACTION/ACTIVITY EVALUATION METHODS
Despite the large number of applications and studies related to
the use of MEA-based systems, there are still a few universally
accepted methodologies to extract information to assess neuro-
toxicity. While bursting behavior and bursting synchronization
over active channels are important criteria for verifying the matu-
ration of the in vitro neuronal network (i.e., quality of the activity),
burst parameters such asmean bursting rate, burst duration,mean
spikes in burst, etc., that were shown to provide important infor-
mation for basic research (e.g., Wagenaar et al., 2006; Novellino
et al., 2007), did not give any particular advantage for neuro-
toxicity assessment. As the burst parameters are extracted from
spike trains the accuracy and reliability were mostly the same
as the MFR (data not shown), while the computation time and
complexity were higher. Available methods are based on spike
detection algorithms that produce multi-site spike, which can be
further analyzed for spike sorting, ﬁrst and higher order statis-
tics (e.g., burst analysis) and cross correlation based methods. A
recent paper from Maccione et al. (2009) demonstrated that the
accuracy of spike detection methods is quite comparable, and if
the goal of the study is not the precise timing but rather the aver-
age effects on a large binning window (e.g., 1min of activity)
the computational requirement for accurate spike detection is not
necessary since a simple spike threshold identiﬁcation provides a
simple yet sufﬁcient method.
EFFECTS OF ADMINISTERED CHEMICALS
The results of this blinded study consistently determined the effects
for 20 chemicals based on the inhibition of spontaneous neuronal
network activity (i.e.,MFR at neuronal network level). Indeed, the
estimated IC50 values for all 20 compounds were within less than
oneorder of magnitude. This reproducibility,despite differences in
sources of cells and age at recording, demonstrates the robustness
of MEA approaches for neurotoxicity tests. For this investigation
a wide range of concentrations have been explored, spanning
through six orders of magnitude, from 100 pM to 100μM. The
lowest did not show signiﬁcant activity variations, but have been
useful to test the robustness of the system in regard to mechani-
cal manipulation. Furthermore, given the sensibility of the system
and the explorative nature of the study, it was considered useful to
test a wide range of concentrations. The MEA-based paradigm can
be very helpful for recognizing toxic and non-toxic compounds in
a middle throughput screening assay. Although it is useful that
the assay accurately and sensitively predict the toxic range of a
substance, in case of chemical labeling and risk assessment the
most important question is whether the chemical is toxic and
which is the order of magnitude of the concentration in which
it starts being toxic. Following this approach, the estimated IC50
are indicative of the order of magnitude of the registered effects in
order to deal with the obtained results, and notmeant to constitute
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a precise toxicological characterization of the analytes. Reﬁnement
of the employed conditions is surely required for a more precise
and reﬁned description of the action mechanism of the different
substances.
The tested substances were supposed to fall into three main
groups according their biological activities based on legal clas-
siﬁcation (EBC–JRC) and published in vivo data, namely (1)
non-neuroactive and non-toxic, (2) toxic but non-neuroactive and
(3) neuroactive substances. The substances of the ﬁrst two groups
showed no detectable effect on neuronal activity in NN MEA,
with the exception of Aniline, which caused a gradual increase in
MFR. This represents the only false positive detected in this study.
The slight increase in MFR registered following 1,2-Propandiol
administration was not signiﬁcant, and likely connected to unspe-
ciﬁc effects. Regarding the 13 substances classiﬁed as neuroactive
in vivo, the NN MEA assay registered nine substances causing a
signiﬁcant decrease of the MFR, one substance (nicotine) giving
a signiﬁcant increase at the highest concentration, and three sub-
stances, namely ethanol, mepiquat, and toluene, that showed no
signiﬁcant activity.
In vitro active neuroactive substances
All theMFR reductions registered in the present paper, either com-
plete or partial, have been registered following the application
substances belonging to this group.
Trimethyltin chloride. In agreement with its high neurotoxicity,
trimethyltin chloride demonstrated the strongest action on corti-
cal network activity between the tested chemicals. The registered
behavior is in agreement with a previous study on MEAs report-
ing an EC50 of 4.3μM for auditory cortex and 1.5μM for spinal
cord tissue derived from mouse embryonic tissue (Gramowski
et al., 2000). Moreover, Kuramoto et al. (2011) showed in pri-
mary mouse cultures that trimethyltin toxicity is initially caused
by activation of the caspase pathway in cortical neurons, which
is in agreement with our recovery result, that show no reversible
network activity on the next day.
Nicotine. In our experiment, nicotine showed an increase of the
MFR at the highest tested concentration (100μM). This result is
apparently in contrast with its high potency in vivo. To date, the
exact role of brain nAChRs is already a debated topic. In vivo,
nicotine effects are variable depending on the subtype and den-
sity of the different nicotinic receptors existing in the distinct
brain regions (Toledano et al., 2010). A high density of nicotine
receptors is found in the thalamus, caudate nucleus, and substan-
tia nigra (Paterson and Nordberg, 2000), composed by various
homomeric or heteromeric combinations of 12 different subunits
(Mansvelder et al., 2009). Their location in the brain is not lim-
ited to postsynaptic but also to pre-, peri-, and extra-synaptic sites
where theymaymodulate neuronal function by a variety of actions
(Lindstro, 1997). In particular, presynaptic nAChRs exist on sev-
eral cell populations in cortical, hippocampal, and cerebellar brain
regions (Wonnacott, 1997).Although a subset of nAChRs are post-
synaptic located on a subset of GABAergic interneurons in cortical
layer, nAChRs in cortex are mostly found on afferent terminals, in
particular from thalamic neurons (Matherate, 2004), and conse-
quently not present in cortical neuron preparations. This nAChRs
distribution in the brain may explain the slight increase of activity
at the highest concentration in NN MEA. In addition it suggests a
need to consider different brain regions in NN MEA assays.
Fipronil. The initial excitatory effect is probably caused by the
antagonist action on GABAa receptors, while the ﬁnal inhibition
might be due to a neurotoxic effect that affect the generation of
spontaneous oscillatory activity of the network.
Eugenol. Eugenol showed, somehowunexpectedly, a rather strong
neuroactive action. Eugenol’s effects on sensorial peripheral nerves
have been studied, but there are few papers on its action on CNS.
In a recent report, rat neocortical and hippocampal slices, eugenol
(10–100μM) showed inhibitory effects on elicited epileptiform
discharges and potassium-induced spreading depression (Müller
et al., 2006). Another study reported decreased population spikes
amplitude in hippocampal slices (Ardjmand et al., 2006). The
discussed ﬁndings are in accordance with our observation of a
clear-cut inhibitory effect starting at 10μM with almost complete
cessation at 100μM.
In vitro not-active neuroactive substances
As previously discussed, three substances belonging to the neu-
roactive group, showed no impairment of electrical activity in
our experiment.
Toluene, despite its well known neurotoxic actions, did not
show any effect in our experiments (the slight decrease of activity
at 100 pM is likely due to the mechanical manipulation rather
than a true substance-related effect). Toluene volatility could
have diminished its availability for the cultured neurons, even
if after administration MEAs have been covered with semiper-
meable caps to avoid evaporation. Indeed, a transient decrease
of network activity has been observed immediately after the
administration of the maximum concentration, but disappeared
a few minutes later (data not shown, personal observation of
the experimenter).
Regarding ethanol, it is worth noting that the maximum con-
centration of 100μM in our tests equals a blood alcohol level
of 0.005% which does not cause pronounced effects in humans.
Accordingly, the lack of effects on neuronal network activity at
lower concentrations has previously been reported; initial inhibi-
tion was only observed at 20mM and total activity cessation at
100mM (Xia and Gross, 2003).
Also Mepiquat chloride had no effect on our experiments, even
if neurotoxicity has been reported in in vivo studies. The ﬁrst mild
diminution in activity at the ﬁrst tested concentration that results
as statistically signiﬁcant is probably due to mechanical manip-
ulation. Interestingly, Mepiquat neuroactive effects are already in
partmediated by nicotinic receptor binding (EFSA, 2008), and this
could be a critical aspect to detect in cortical neurons network as
discussed for nicotine effects.
The evaluation of the effects on MFR after substance adminis-
tration is certainly informative about neuronal activity, but is not a
clear description for a neuroactive effect. A strong cytotoxic com-
pound will end in a total cessation too, by measuring the electrical
activity. Therefore it is important to test also cytotoxic markers to
be able to distinguish between neuroactive and cytotoxic effects.
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We decided to investigate in a ﬁrst experiment the recovery of
the neuronal networks after a wash-out of the chemical substance
as an indicator for cytotoxicity. Some of the substances showed
absolutely no recovery (as shown, e.g., for TMT), the majority of
substances showed a moderate recovery of activity, between 35
and 70%, which makes it difﬁcult to distinguish between incom-
plete recovery, already present chemical agent, cytotoxic actions, or
other effects related to manipulation. Multiple medium exchanges
would be required to achieve a total wash-out, especially for water
insoluble compounds, and together with different times of recov-
ery before registration could help in generating more clear data.
However, looking at a method to get information about the way
of toxicity action of different substances, we propose that other
endpoints could be more informative as an integration to electro-
physiological measurements, such as the cytotoxicity assessment
(for example by measuring the release of lactate dehydrogenase
into the culture medium), or the evaluation of the metabolic state
of the cells. The alterations of electrical activity induced by a com-
pound’s application (functional neuroactivity) is indeed often not
associated to cell death (cytotoxicity), or direct cellular physiol-
ogy impairment. This is consistent with the acute neurotoxicity
of many xenobiotics (e.g., ethanol, pyrethroids, tetrodotoxin, etc.)
that cause the organism death prior to the onset of signiﬁcant
cytotoxicity in the nervous system. While not examined in these
experiments, other studies (Novellino et al., 2011) showed that the
compounds modiﬁed neuronal network activity in the absence
of cytotoxicity. The evaluation of the previously mentioned
endpoints could help in distinguishing between the different
toxic effects.
CONCLUSION
For toxicological prediction of a compound, the detection and
characterization of chemical-induced toxic effects in the central
and peripheral nervous system represents a major challenge for
employing newly developed technologies in the ﬁeld of neurotox-
icity (Dunlop et al., 2008). The use of neuronal cultures growing
on MEAs innovates the ﬁeld of neurotoxicity: a neuronal network
coupled to MEA represents a simpliﬁed model of the nervous
system in which the electric activity is measured in real-time
while being exposed to tested substances. The presented feasi-
bility study provides a further evidence of the potential use and
usefulness of the proposed paradigm as an alternative method for
gathering neurotoxicity information for chemical risk assessment,
especially under a chemical industry perspective. So far the assay
appears to be a reliable tool to exclude neuroactivity of chemicals
in an early screening, and therefore we shall extend the evalua-
tion of the NN MEA as a screening tool for the neurotoxic effects
of chemicals.
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